Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Apr 17, 16:00
Sinovac Biotech Revenue (TTM): 420.88M for June 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2020 | 510.62M |
| September 30, 2020 | 264.28M |
| June 30, 2020 | 213.17M |
| March 31, 2020 | 224.89M |
| December 31, 2019 | 246.05M |
| September 30, 2019 | 218.15M |
| June 30, 2019 | 207.76M |
| March 31, 2019 | 218.87M |
| December 31, 2018 | 229.65M |
| September 30, 2018 | 207.80M |
| June 30, 2018 | 182.59M |
| March 31, 2018 | 108.82M |
| December 31, 2016 | 72.43M |
| September 30, 2016 | 64.02M |
| June 30, 2016 | 52.05M |
| March 31, 2016 | 69.16M |
| December 31, 2015 | 67.41M |
| September 30, 2015 | 64.61M |
| June 30, 2015 | 64.99M |
| March 31, 2015 | 58.59M |
| December 31, 2014 | 62.93M |
| September 30, 2014 | 64.98M |
| June 30, 2014 | 69.91M |
| March 31, 2014 | 75.27M |
| December 31, 2013 | 71.77M |
| Date | Value |
|---|---|
| September 30, 2013 | 69.17M |
| June 30, 2013 | 61.38M |
| March 31, 2013 | 53.29M |
| December 31, 2012 | 49.22M |
| September 30, 2012 | 50.77M |
| June 30, 2012 | 51.84M |
| March 31, 2012 | 58.13M |
| December 31, 2011 | 56.74M |
| September 30, 2011 | 44.74M |
| June 30, 2011 | 38.93M |
| March 31, 2011 | 33.54M |
| December 31, 2010 | 33.40M |
| September 30, 2010 | 60.65M |
| June 30, 2010 | 72.32M |
| March 31, 2010 | 82.08M |
| December 31, 2009 | 84.20M |
| September 30, 2009 | 60.17M |
| June 30, 2009 | 47.70M |
| March 31, 2009 | 44.20M |
| December 31, 2008 | 46.50M |
| September 30, 2008 | 43.34M |
| June 30, 2008 | 45.41M |
| March 31, 2008 | 35.65M |
| December 31, 2007 | 33.04M |
| September 30, 2007 | 27.68M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
207.76M
Minimum
Jun 2019
510.62M
Maximum
Dec 2020
269.28M
Average
224.89M
Median
Mar 2020
Revenue (TTM) Benchmarks
| CASI Pharmaceuticals Inc | 33.88M |
| Zai Lab Ltd | 266.72M |
| I-MAB | -35.63M |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | 18.11M |